msGUIDE is by definition a highly interdisciplinary project that requires synergy between engineering, optics, physics (provided by HelmholtzMunich, EMC and Statice), chemistry, pharmacology, and medicine (provided by UMCG). The consortium consists of world-renowned scientists with expertise that spans throughout the compulsory disciplines.

HelmholtzMunich and EMC have a longstanding expertise in developing and characterizing FMI systems and with UMCG drives the clinical translation of Fluorescence Molecular Imaging for guided surgery at a worldwide level. Within the UMCG department of Gastroenterology and Hepatology, there is ample experience with multidisciplinary treatment of IBD patients, with world-leading expertise in clinical translation of FMI and FME (Fluorescence Molecular Endoscopy), and development of targeted fluorescence agents for clinical use. The efforts by those three academic partners will be significantly supported by Statice, an SME partner specialized in the development and manufacturing of medical devices for legal manufacturer since 1978. As such, the participation of Statice in msGUIDE will guarantee the successful completion of the radically novel objectives, as well as for the exploitation of the main results. Finally, SME partner LaNova as an expert on medical devices and pharma will streamline the regulatory documentation and the exploitation of our unique innovations within msGUIDE. The company, originally founded in 2000, draws on more than 20 years of expertise in the healthcare sector and is based in Czech Republic.